Full Text View
Tabular View
No Study Results Posted
Related Studies
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.
This study has been completed.
Study NCT00482430   Information provided by Merck

First Received on May 31, 2007.   Last Updated on November 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Paranoid Schizophrenia
Schizophrenia
Additional conditions recognized in this trial
Cognition Disorders
Schizophrenia, Paranoid
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
MK0557
Comparator: Placebo (unspecified)
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services